432
Views
7
CrossRef citations to date
0
Altmetric
Clinical Trial Evaluation

Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) confirms that abaloparatide is a valuable addition to the armamentarium against osteoporosis

, &
Pages 1811-1813 | Received 23 Aug 2017, Accepted 17 Oct 2017, Published online: 14 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gilberto Li Feng, Marc D Grynpas & Jane Mitchell. (2023) β-Arrestin 2 knockout prevents bone loss in response to continuous parathyroid hormone stimulation in male and female mice. Connective Tissue Research 64:4, pages 350-361.
Read now

Articles from other publishers (6)

René Rizzoli. (2023) Combined and sequential therapies with anabolic and antiresorptive drugs in the management. International Journal of Bone Fragility 3:1, pages 7-15.
Crossref
René Rizzoli. 2022. Senior Trauma Patients. Senior Trauma Patients 107 119 .
. (2021) Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause 28:9, pages 973-997.
Crossref
Yuehong Chen, Ronghan Liu, Aubryanna Hettinghouse, Shuya Wang, Gang Liu & Chuan-ju Liu. (2019) Clinical Application of Teriparatide in Fracture Prevention. JBJS Reviews 7:1, pages e10-e10.
Crossref
Manoj K. Pandey, Subash C. Gupta, Deepkamal Karelia, Patrick J. Gilhooley, Mehdi Shakibaei & Bharat B. Aggarwal. (2018) Dietary nutraceuticals as backbone for bone health. Biotechnology Advances 36:6, pages 1633-1648.
Crossref
René Rizzoli. (2018) Postmenopausal osteoporosis: Assessment and management. Best Practice & Research Clinical Endocrinology & Metabolism 32:5, pages 739-757.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.